TRML
Tourmaline Bio
TRML
TRML
Delisted
TRML was delisted on the 27th of October, 2025.
54 hedge funds and large institutions have $338M invested in Tourmaline Bio in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 26 increasing their positions, 4 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
50% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 14
13% more funds holding
Funds holding: 48 → 54 (+6)
Holders
54
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$36.3M | |
| 2 | +$26.7M | |
| 3 | +$20.2M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$18.1M |
| 5 |
QF
QVT Financial
New York
|
+$17.8M |
Top Sellers
| 1 | -$22.7M | |
| 2 | -$6.75M | |
| 3 | -$738K | |
| 4 |
JP Morgan Chase
New York
|
-$687K |
| 5 |
AI
Acuitas Investments
Seattle,
Washington
|
-$547K |